These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12173723)

  • 41. Surgical delay in acute admissions on warfarin: are we doing enough?
    Tharmarajah P
    Int J Clin Pract; 2007 Jul; 61(7):1233. PubMed ID: 17577302
    [No Abstract]   [Full Text] [Related]  

  • 42. Updated guidelines on outpatient anticoagulation.
    Wigle P; Hein B; Bloomfield HE; Tubb M; Doherty M
    Am Fam Physician; 2013 Apr; 87(8):556-66. PubMed ID: 23668445
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potentiation of warfarin sodium by amiodarone-induced thyrotoxicosis.
    Woeber KA; Warner I
    West J Med; 1999 Jan; 170(1):49-51. PubMed ID: 9926737
    [No Abstract]   [Full Text] [Related]  

  • 44. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Ridker PM; Goldhaber SZ; Danielson E; Rosenberg Y; Eby CS; Deitcher SR; Cushman M; Moll S; Kessler CM; Elliott CG; Paulson R; Wong T; Bauer KA; Schwartz BA; Miletich JP; Bounameaux H; Glynn RJ;
    N Engl J Med; 2003 Apr; 348(15):1425-34. PubMed ID: 12601075
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term anticoagulation prophylaxis following acute thromboembolism.
    Hyers TM
    Dis Mon; 2005; 51(2-3):158-65. PubMed ID: 15900268
    [No Abstract]   [Full Text] [Related]  

  • 46. A patient with a prolonged prothrombin time due to an adverse interaction between 5-fluorouracil and warfarin.
    Aki Z; Kotiloğlu G; Ozyilkan O
    Am J Gastroenterol; 2000 Apr; 95(4):1093-4. PubMed ID: 10763974
    [No Abstract]   [Full Text] [Related]  

  • 47. [Early and loud].
    Schellong S
    Vasa; 2003 May; 32(2):59-60. PubMed ID: 12945096
    [No Abstract]   [Full Text] [Related]  

  • 48. Outcomes of pharmacogenetics-guided dosing of warfarin: a systematic review and meta-analysis.
    Tang Q; Zou H; Guo C; Liu Z
    Int J Cardiol; 2014 Aug; 175(3):587-91. PubMed ID: 25005340
    [No Abstract]   [Full Text] [Related]  

  • 49. Prospective evaluation of a modified Fennerty regimen for anticoagulating elderly people.
    Cooper MW; Hendra TJ
    Age Ageing; 1998 Sep; 27(5):655-6. PubMed ID: 12675109
    [No Abstract]   [Full Text] [Related]  

  • 50. Seven cases of interaction between warfarin and cyclooxygenase-2 inhibitors.
    Stading JA; Skrabal MZ; Faulkner MA
    Am J Health Syst Pharm; 2001 Nov; 58(21):2076-80. PubMed ID: 11715832
    [No Abstract]   [Full Text] [Related]  

  • 51. Possible interaction between warfarin and quetiapine.
    Rogers T; de Leon J; Atcher D
    J Clin Psychopharmacol; 1999 Aug; 19(4):382-3. PubMed ID: 10440472
    [No Abstract]   [Full Text] [Related]  

  • 52. The patients' perspective of international normalized ratio self-testing, remote communication of test results and confidence to move to self-management.
    Grogan A; Coughlan M; Prizeman G; O'Connell N; O'Mahony N; Quinn K; McKee G
    J Clin Nurs; 2017 Dec; 26(23-24):4379-4389. PubMed ID: 28231618
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Elevated International Normalized Ratio After Initiation of Niacin and Niacinamide Chemoprophylaxis for Patients on Warfarin.
    Markham DJ; Barbosa NS; Degesys CA
    Dermatol Surg; 2024 Jul; 50(7):690-692. PubMed ID: 38422208
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical trials for pharmacogenomics testing for warfarin dosing: relevance to general community practices.
    Sidiropoulos N; Wu AH
    Genet Med; 2011 Jun; 13(6):505-8. PubMed ID: 21555943
    [No Abstract]   [Full Text] [Related]  

  • 55. Oral anticoagulants and regional anesthesia: a perspective.
    Enneking FK; Benzon H
    Reg Anesth Pain Med; 1998; 23(6 Suppl 2):140-5. PubMed ID: 9845386
    [No Abstract]   [Full Text] [Related]  

  • 56. Cluster randomized trials: another look.
    Macklin R
    Hastings Cent Rep; 2014; 44(1):37-43. PubMed ID: 24375386
    [No Abstract]   [Full Text] [Related]  

  • 57. Dosing guidelines, not protocols, for managing warfarin therapy.
    Wittkowsky AK; Spinler SA; Dager W; Gulseth MP; Nutescu EA
    Am J Health Syst Pharm; 2010 Sep; 67(18):1554-6. PubMed ID: 20811035
    [No Abstract]   [Full Text] [Related]  

  • 58. Warfarin dosing changes after bariatric surgery: implications on the mechanism for altered dose requirements and safety concerns--an alternative viewpoint.
    Chan LN
    Pharmacotherapy; 2014; 34(4):e26-8. PubMed ID: 24753156
    [No Abstract]   [Full Text] [Related]  

  • 59. Ask the doctors. There is a long list of drugs and substances that interact with Coumadin (warfarin). Does this mean they make Coumadin more effective, or less effective?
    Lee TH; Lee RT
    Harv Heart Lett; 2013 Sep; 24(1):2. PubMed ID: 24386674
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of levofloxacin coadministration on the international normalized ratios during warfarin therapy--a comment.
    Glasheen JJ; Fugit RV; Prochazka AV
    Pharmacotherapy; 2003 Aug; 23(8):1079-80; discussion 1080. PubMed ID: 12921255
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.